Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Immix Biopharma, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 16 | 28 | +12 |
| Shares | 405.1K | 781.8K | +376.8K (+93.0%) |
| Value | $1.39M | $5.32M | +$3.93M (+283.7%) |
New holders (13)
Institutions that held Immix Biopharma, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 102,661 | $710.4K | 0.13% |
| Private Advisor Group, LLC | 99,775 | $690.4K | 0.01% |
| Renaissance Technologies LLC | 32,400 | $224.0K | 0.00% |
| Northern Trust Corp | 24,378 | $168.7K | 0.00% |
| Jump Financial, LLC | 18,500 | $128.0K | 0.00% |
| Jane Street Group, LLC | 14,922 | $103.3K | 0.00% |
| Susquehanna International Group, LLP | 14,351 | $99.3K | 0.00% |
| Bank of Montreal | 10,000 | $72.0K | 0.00% |
| Old National Bancorp | 10,000 | $69.2K | 0.00% |
| UBS Group AG | 2,628 | $18.2K | 0.00% |
| Bank of America Corp | 1,594 | $11.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 577 | $3.99K | 0.00% |
| Royal Bank of Canada | 68 | $0 | 0.00% |
Sold out (1)
Institutions that held Immix Biopharma, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Koshinski Asset Management, Inc. | 51,001 | $174.4K |